Greyhound Sport Medicine Ltd 07368373 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is veterinary practice Digita Accounts Production Advanced 6.30.9574.0 true 07368373 2024-04-01 2025-03-31 07368373 2025-03-31 07368373 core:CurrentFinancialInstruments 2025-03-31 07368373 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 07368373 core:Non-currentFinancialInstruments 2025-03-31 07368373 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 07368373 core:FurnitureFittings 2025-03-31 07368373 core:LandBuildings core:OwnedOrFreeholdAssets 2025-03-31 07368373 core:OfficeEquipment 2025-03-31 07368373 bus:SmallEntities 2024-04-01 2025-03-31 07368373 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 07368373 bus:FilletedAccounts 2024-04-01 2025-03-31 07368373 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07368373 bus:RegisteredOffice 2024-04-01 2025-03-31 07368373 bus:Director1 2024-04-01 2025-03-31 07368373 bus:Director3 2024-04-01 2025-03-31 07368373 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07368373 bus:Agent1 2024-04-01 2025-03-31 07368373 core:FurnitureFittings 2024-04-01 2025-03-31 07368373 core:LandBuildings core:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 07368373 core:OfficeEquipment 2024-04-01 2025-03-31 07368373 countries:EnglandWales 2024-04-01 2025-03-31 07368373 2024-03-31 07368373 core:FurnitureFittings 2024-03-31 07368373 core:LandBuildings core:OwnedOrFreeholdAssets 2024-03-31 07368373 core:OfficeEquipment 2024-03-31 07368373 2023-04-01 2024-03-31 07368373 2024-03-31 07368373 core:CurrentFinancialInstruments 2024-03-31 07368373 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 07368373 core:Non-currentFinancialInstruments 2024-03-31 07368373 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 07368373 core:FurnitureFittings 2024-03-31 07368373 core:LandBuildings core:OwnedOrFreeholdAssets 2024-03-31 07368373 core:OfficeEquipment 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 07368373

Greyhound Sport Medicine Ltd
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2025

Greyhound Sport Medicine Ltd

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 4 to 8

Greyhound Sport Medicine Ltd

Company Information

Directors | S Malegori M Marino

Registered office | 5 Ducketts Wharf South Street Bishops Stortford Hertfordshire CM23 3AR

Accountants | Mansell & Co Chartered Certified Accountants5 Ducketts Wharf South Street Bishop Stortford Hertfordshire CM23 3AR

Greyhound Sport Medicine Ltd

(Registration number: 07368373)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 553,897 | 557,922
Current assets |  |  |
Stocks | 5 | 11,973 | 11,399
Debtors | 6 | 56,994 | 43,878
Cash at bank and in hand |  | 141,965 | 73,273
|  | 210,932 | 128,550
Creditors: Amounts falling due within one year | 7 | (77,861) | (67,392)
Net current assets |  | 133,071 | 61,158
Total assets less current liabilities |  | 686,968 | 619,080
Creditors: Amounts falling due after more than one year | 7 | (21,622) | (36,586)
Net assets |  | 665,346 | 582,494
Capital and reserves |  |  |
Called up share capital | 8 | 60 | 60
Retained earnings |  | 665,286 | 582,434
Shareholders' funds |  | 665,346 | 582,494

Greyhound Sport Medicine Ltd

(Registration number: 07368373)
Balance Sheet as at 31 March 2025

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 18 September 2025 and signed on its behalf by:

......................................... S Malegori Director
......................................... M Marino Director

Greyhound Sport Medicine Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
5 Ducketts Wharf
South Street
Bishops Stortford
Hertfordshire
CM23 3AR
England

These financial statements were authorised for issue by the Board on 18 September 2025.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Greyhound Sport Medicine Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Fixtures and fittings | 25% - reducing balance
Equipment | 25% - reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Greyhound Sport Medicine Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 3).

Greyhound Sport Medicine Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4 | Tangible assets

| Land and buildings £ | Fixtures and fittings £ | Office equipment £ | Total £
Cost or valuation
At 1 April 2024 | 550,000 | 40,784 | 47,238 | 638,022
At 31 March 2025 | 550,000 | 40,784 | 47,238 | 638,022
Depreciation
At 1 April 2024 | - | 35,801 | 44,299 | 80,100
Charge for the year | - | 1,246 | 2,779 | 4,025
At 31 March 2025 | - | 37,047 | 47,078 | 84,125
Carrying amount
At 31 March 2025 | 550,000 | 3,737 | 160 | 553,897
At 31 March 2024 | 550,000 | 4,983 | 2,939 | 557,922

Included within the net book value of land and buildings above is £550,000 (2024 - £550,000) in respect of freehold land and buildings.

5 | Stocks

| 2025 £ | 2024 £
Other inventories | 11,973 | 11,399

6 | Debtors

Current | 2025 £ | 2024 £
Trade debtors | 56,994 | 43,878
| 56,994 | 43,878

Greyhound Sport Medicine Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

7 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Trade creditors | 6,211 | 6,917
Taxation and social security | 66,922 | 56,358
Accruals and deferred income | 2,232 | 2,247
Other creditors | 2,496 | 1,870
| 77,861 | 67,392

Creditors: amounts falling due after more than one year

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 9 | 21,622 | 36,586

8 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Shares of £1 each | 60 | 60 | 60 | 60

9 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 1,622 | 16,586
Other borrowings | 20,000 | 20,000
| 21,622 | 36,586